Reactive arthritis: case reportA 69-year-old man developed reactive arthritis during treatment with BCG for carcinoma in situ of the bladder (CisB). The man presented with fever, asymmetric, bilateral and painful arthritis of tibiotarsal, interphalangeal and knee joints along with functional disability without any relief with opioids (unspecified). He also had bilateral conjunctivitis and redness of glans and scrotum, which was suggestive of urethritis (reactive arthritis) [duration of treatment to reaction onset not stated]. He had a pacemaker, and his medical history included C4-C5 arthroplasty, coronary stent placement (treated with acetylsalicylic acid), endovascular abdominal aortic aneurysm repair, recurrent gout (receiving treatment with colchicine and allopurinol) and CisB. For CisB, he had been receiving intravesical BCG [dosage not stated]. He received the fifth dose of BCG 5 days prior to the onset of the symptoms of reactive arthritis. Laboratory tests revealed high levels of inflammation (sedimentation rate and C-reactive protein) and serum uric acid. Whereas, prostate-specific antigen was slightly increased. Initially, he was maintained on colchicine. He was started on antibiotic therapy with ceftriaxone, which was later changed to piperacillin/tazobactam and vancomycin because of increased CRP, persistent fever and no clinical improvement. He then underwent a diagnostic arthrocentesis. Based on further investigations and negative culture of the joint fluid, microcrystalline arthritis was ruled out, and septic arthritis was considered less probable.Due to no improvement of arthritis, the man was started on prednisolone, following which some pain relief was noted with no fever 24 hours later. After 1 week, his inflammatory tests were also normal. Blood and urine cultures and serological tests were negative. Test for human leukocyte antigen-B27 was positive, while other immunological tests were normal. Because of the presence of medical devices, antibiotic therapy was continued throughout the aetiological investigation. Based on transoesophageal echocardiography and thoracic-abdominal-pelvic CT scan, endocarditis and infectious foci were excluded. His physical rehabilitation was continued. Despite slow clinical improvement, corticosteroid therapy was gradually reduced, and a complete resolution of reactive arthritis was noted after 1 year. He was not restarted on BCG, and no evidence of CisB was observed at 2 years follow-up.